Astec LifeSciences Limited — Others, 28-07-2025: Shareholders meeting

Astec LifeSciences held its 31st Annual General Meeting where shareholders adopted the financial statements for FY2024-25. The company reported a total income of ₹386.93 Crore and a loss after tax of ₹134.71 Crore for the fiscal year, impacted by a challenging agrochemical market. Shareholders approved the re-appointment of Mr. Nadir B. Godrej as Director and the appointment of the Cost and Secretarial Auditors. Notably, a proposed resolution seeking approval for related party transactions with holding company Godrej Agrovet, exceeding materiality thresholds, did not receive shareholder approval. This indicates a key shareholder view on related party dealings.